Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

ClinicalTrials.gov ID: NCT05691244

Public ClinicalTrials.gov record NCT05691244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jun 26, 2026, 4:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicentric, Randomized, Double-blind, Parallel, Placebo-controlled Phase III Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke.

Study identification

NCT ID: NCT05691244
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Pharmazz, Inc.; Industry
Enrollment: 514 participants

Conditions and interventions

Conditions

Interventions

Drug: Normal Saline Drug
Sovateltide Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 23, 2025
Primary completion: Aug 31, 2026
Completion: Oct 31, 2026
Last update posted: Jun 23, 2026

2025 – 2026

United States locations

U.S. sites: 14
U.S. states: 11
U.S. cities: 13

Facility	City	State	ZIP	Site status
The University of Arizona - College of Medicine	Tucson	Arizona	85719	Recruiting
Mercy Medical Group	Carmichael	California	95608	Recruiting
St. John's Regional Medical Center	Oxnard	California	93030	Recruiting
Sarasota Memorial Hospital	Sarasota	Florida	34239	Recruiting
Wellstar Kennestone Hospital	Marietta	Georgia	30060	Recruiting
SSM Health Neurosciences	Bridgeton	Missouri	63044	Recruiting
Hackensack University Medical Center at Paramus	Paramus	New Jersey	07652	Recruiting
Guilford Neurologic Associates Inc	Greensboro	North Carolina	27401	Recruiting
OSU Wexner Medical Center	Columbus	Ohio	43210	Recruiting
Penn State Health Milton S. Hershey Medical Center	Hershey	Pennsylvania	17033	Recruiting
UPMC Presbyterian Hospital	Pittsburgh	Pennsylvania	15213	Recruiting
CHI Memorial Neuroscience Institute	Chattanooga	Tennessee	37404	Recruiting
Houston Medical Neurological Institute	Houston	Texas	77030	Recruiting
Memorial Hermann Hospital	Houston	Texas	77030	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05691244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 23, 2026 · Synced Jun 26, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05691244 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →